Abstract

Access to diagnosis and treatment of pulmonary hypertension remains difficult for clinicians. Essential updates on the European Society of Cardiology imaging, severity, and treatment in 2022 and the American   Heart   Association    consensus on perioperative risk assessment   in patients   with   pulmonary   hypertension with noncardiac surgery in 2023 provide a systematic approach to diagnosis and effective treatment.